North American Multiplex Assays: A $5.3 Billion Market by 2027
The multiplex assays market is valued at an estimated USD 3.5 billion in 2022 and is projected to reach USD 5.3 billion by 2027, at a CAGR of 8.8% during the forecast period. The increasing applications of companion diagnostics in drug development and the significance of multiplex assays in companion diagnostics are expected to drive the multiplex assays market.
Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=61593314
Based...